AFINITOR
Novartis AG
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77540495 |
| Registration Number | 3778903 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Attorney Docket Number | 51653 |
| Law Office Assigned | M80 |
| Employee Name | SEVERSON, KAREN PATRIC |
Timeline
| 2008-08-06 | Application Filed |
| 2008-11-11 | Published for Opposition |
| 2009-03-30 | Date of First Use |
| 2010-03-17 | Location: PUBLICATION AND ISSUE SECTION |
| 2010-04-20 | Trademark Registered |
| 2016-11-25 | Cancelled |
| 2016-11-25 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novartis AG |
| Address | CH 4002 Basel CH |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for use in oncology |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2008-08-11 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2008-09-15 | 2 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2008-09-23 | 3 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2008-09-23 | 4 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2008-09-23 | 5 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2008-09-23 | 6 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2008-09-23 | 7 CNSA P: |
| ASSIGNED TO LIE | 2008-10-03 | 8 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2008-10-07 | 9 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2008-10-22 | 10 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2008-11-11 | 11 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2009-02-03 | 12 NOAM O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-06-17 | 13 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2009-08-03 | 14 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2009-08-03 | 15 EXT1 S: |
| EXTENSION 1 GRANTED | 2009-08-03 | 16 EX1G S: |
| TEAS EXTENSION RECEIVED | 2010-01-22 | 17 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2010-03-04 | 18 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2010-01-22 | 19 EXT2 S: |
| EXTENSION 2 GRANTED | 2010-03-04 | 20 EX2G S: |
| TEAS STATEMENT OF USE RECEIVED | 2010-03-11 | 21 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2010-03-11 | 22 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2010-03-15 | 23 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2010-03-17 | 24 CNPR P: |
| LAW OFFICE REGISTRATION REVIEW COMPLETED | 2010-03-17 | 25 REGV O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2010-03-18 | 26 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2010-04-20 | 27 R.PR A:Allowance for Publication |
| CANCELLED SEC. 8 (6-YR) | 2016-11-25 | 28 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 AFINITOR 79059629 3639863 Dead/Cancelled |
Novartis AG 2008-09-02 |
 AFINITOR 79023992 3216047 Live/Registered |
Novartis AG 2006-03-23 |
 AFINITOR 77675030 3785901 Dead/Cancelled |
Novartis AG 2009-02-20 |
 AFINITOR 77540495 3778903 Dead/Cancelled |
Novartis AG 2008-08-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 